These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


531 related items for PubMed ID: 3178716

  • 1. Effects of ciprofibrate and 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acetyltransferase activity.
    Bhuiyan AK, Bartlett K, Sherratt HS, Agius L.
    Biochem J; 1988 Jul 15; 253(2):337-43. PubMed ID: 3178716
    [Abstract] [Full Text] [Related]

  • 2. Characterization of ciprofibrate and clofibric acid as peroxisomal proliferators in primary cultures of rat hepatocytes.
    Feller DR, Singh Y, Shirhatti VR, Kocarek TA, Liu CT, Krishna G.
    Hepatology; 1987 Jul 15; 7(3):508-16. PubMed ID: 3570161
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Metabolic changes in fed rats caused by chronic administration of ethyl 2[5(4-chlorophenyl)pentyl]oxirane-2-carboxylate, a new hypoglycaemic compound.
    Koundakjian PP, Turnbull DM, Bone AJ, Rogers MP, Younan SI, Sherratt HS.
    Biochem Pharmacol; 1984 Feb 01; 33(3):465-73. PubMed ID: 6231030
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of POCA on metabolism and function in the ischemic rat heart.
    Paulson DJ, Noonan JJ, Ward KM, Stanley H, Sherratt A, Shug AL.
    Basic Res Cardiol; 1986 Feb 01; 81(2):180-7. PubMed ID: 3741356
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interactions of inhibitors of carnitine palmitoyltransferase I and fibrates in cultured hepatocytes.
    Gerondaes P, Alberti KG, Agius L.
    Biochem J; 1988 Jul 01; 253(1):169-73. PubMed ID: 3421940
    [Abstract] [Full Text] [Related]

  • 9. Effects of 2[5(4-chlorphenyl)pentyl]oxirane-2-carboxylate on fatty acid synthesis and fatty acid oxidation in isolated rat hepatocytes.
    Agius L, Pillay D, Alberti KG, Sherratt HS.
    Biochem Pharmacol; 1985 Aug 01; 34(15):2651-4. PubMed ID: 2861821
    [Abstract] [Full Text] [Related]

  • 10. Effect of the peroxisome proliferator ciprofibrate on hepatic DNA synthesis and hepatic composition following partial hepatectomy in rats.
    Srinivasan SR, Chow CK, Glauert HP.
    Toxicology; 1990 Jun 01; 62(3):321-32. PubMed ID: 2389247
    [Abstract] [Full Text] [Related]

  • 11. Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on intermediary metabolism in isolated rat-liver cells.
    Vaartjes WJ, De Haas CG, Haagsman HP.
    Biochem Pharmacol; 1986 Dec 01; 35(23):4267-72. PubMed ID: 3790153
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Action in vivo and in vitro of 2-tetradecylglycidic acid, 2-tetradecylglycidyl-CoA and 2-tetradecylglycidylcarnitine on hepatic carnitine palmitoyltransferase.
    Brady PS, Brady LJ.
    Biochem J; 1986 Sep 15; 238(3):801-9. PubMed ID: 3800962
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strain. Co-induction of microsomal cytochrome P-450 IVA1 and peroxisome proliferation.
    Makowska JM, Anders C, Goldfarb PS, Bonner F, Gibson GG.
    Biochem Pharmacol; 1990 Sep 01; 40(5):1083-93. PubMed ID: 2390105
    [Abstract] [Full Text] [Related]

  • 16. Interaction of carnitine and propionate with pyruvate oxidation by hepatocytes from clofibrate-treated rats: importance of coenzyme A availability.
    Brass EP.
    J Nutr; 1992 Feb 01; 122(2):234-40. PubMed ID: 1732464
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of carnitine palmitoyltransferase 1 by phenylalkyloxiranecarboxylic acid and its influence on lipolysis and glucose metabolism in isolated, perfused hearts of streptozotocin-diabetic rats.
    Rösen P, Reinauer H.
    Metabolism; 1984 Feb 01; 33(2):177-85. PubMed ID: 6694560
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine.
    Lopaschuk GD, Wall SR, Olley PM, Davies NJ.
    Circ Res; 1988 Dec 01; 63(6):1036-43. PubMed ID: 3197271
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.